InvestorsHub Logo
Followers 20
Posts 2690
Boards Moderated 1
Alias Born 12/03/2020

Re: cowtown jay post# 142309

Friday, 01/22/2021 10:46:53 AM

Friday, January 22, 2021 10:46:53 AM

Post# of 233462
I disagree. most biotechs dont have toxic loans like Cytodyn. Most don't have history of over-promising so much. They are not radioactive (shady reputation) nor poisonous (poison pills preventing an acquisition). That makes them very attractive for a potential buyer, because he can trust that he will be able post-acquisition to perform the transactions he needs to bring them to fruition. In Cytodyn's case, there are red flags everywhere. And who knows what has been kept hidden from the public in the drawers.

When Cytodyn's former Chief Medical Officer has a lawsuit, accusing the CEO of exagerating and lying to his own shareholders about the reality of the company, this is hair-raising to any professional investor or acquirer.

A simple statistic, someone called that the "Nader constant failure model": he made more than 30 enthusiastic press releases over the last 3 years. Yet, none of them have been delivered. By delivered, I mean a regulatory approval. 0%. That is not what I see with most biotechs. They may not deliver but PRs are very limited in number, choice of superlative adjectives, carefully worded and not crazily positive. Also most of these startups don't deal with Fife the toxic lender.

This is a very toxic combination and Cytodyn has it. It's I believe a mini-Theranos
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News